Komori
Mochida Pharmaceutical (4534) · RiskRestated

Risk of Personal and Confidential Information Leaks

First written in FY2016. 7 of 8 entries say "Restated". Latest entry: FY2026.

8entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20262016: 120162017: 020172018: 120182019: 120192020: 120202021: 120212022: 120222023: 020232024: 020242025: 120252026: 12026
Same theme, other companies
Confidentiality and Personal Information Leakage RiskA theme 1043 companies write about · 1055 as a headwind · 3 as a tailwind

The whole theme swung hardest in 2026: 13 of 71 companies on the "Worse" side.

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 1058 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「If the Group's confidential information, personal information and other data are leaked outside the company due to unauthorized access to systems, system failures or other reasons, litigation, damages, lower sales resulting from reputational damage and the loss of future sales opportunities could have a material impact on operating results and financial condition.」

    The risks of litigation, damages, reputational damage and loss of sales opportunities arising from information leakage have been reconfirmed.
  2. FY2025RestatedAnnual report

    「If the Group's confidential information, personal information and other data are leaked outside the company due to unauthorized access to systems, system failures or other reasons, litigation, damages, lower sales resulting from reputational damage and the loss of future sales opportunities could have a material impact on operating results and financial condition.」

    The risks of litigation, damages, reputational damage and loss of sales opportunities arising from leakage of confidential and personal information, as well as security measures, have been reconfirmed.
  3. FY2022RestatedAnnual report

    「If the Group's confidential information, personal information and other data are leaked outside the company due to unauthorized access to systems, system failures or other reasons, litigation, damages, lower sales resulting from reputational damage and the loss of future sales opportunities could have a material impact on operating results and financial condition.」

    The risks of litigation, damages, reputational damage and loss of sales opportunities arising from information leakage have been reconfirmed.
  4. FY2021RestatedAnnual report

    「If the Group's confidential information, personal information and other data are leaked outside the company due to unauthorized access to systems, system failures or other reasons, litigation, damages, lower sales resulting from reputational damage and the loss of future sales opportunities could have a material impact on operating results and financial condition.」

    The risks of litigation, damages, reputational damage and loss of sales opportunities arising from leakage of confidential and personal information have been reconfirmed.
  5. FY2020RestatedAnnual report

    「If the Group's confidential information, personal information and other data are leaked outside the company due to unauthorized access to systems, system failures or other reasons, litigation, damages and lower sales resulting from reputational damage could have a material impact on operating results and financial condition.」

    The risk of information leakage and measures through security controls are reiterated.
  6. FY2019RestatedAnnual report

    「The Group has implemented security measures to protect information, including organizational, personnel, physical and technical measures, and is working to strengthen information security. However, if the Group's personal information, confidential information and other data are leaked outside the company due to unauthorized access to systems, system failures or other reasons, the Group faces the risk of incurring unforeseen losses.」

    The risk of information leakage and measures through security controls are reiterated.
  7. FY2018RestatedAnnual report

    「The Group has implemented security measures to protect information, including organizational, personnel, physical and technical measures, and is working to strengthen information security. However, if the Group's personal information, confidential information and other data are leaked outside the company due to unauthorized access to systems, system failures or other reasons, the Group faces the risk of incurring unforeseen losses.」

    The risk of information leakage and measures through security controls are reiterated.
  8. FY2016First statedAnnual report

    「If the Group's personal information, confidential information and other data are leaked outside the company due to unauthorized access to systems, system failures or other reasons, the Group faces the risk of incurring unforeseen losses.」

    The disclosure also states that organizational, personnel, physical and technical security measures have been implemented.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Mochida Pharmaceutical yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of Personal and Confidential Information Leaks | Mochida Pharmaceutical Co.,Ltd. (4534) | Komori